| Osteosarcoma-Tumor-Assessment |
P9-B7-4168-28271 |
P9-B7-4168-28271 |
| Osteosarcoma-Tumor-Assessment |
P9-B7-5454-29446 |
P9-B7-5454-29446 |
| Osteosarcoma-Tumor-Assessment |
P9-B7-6105-28215 |
P9-B7-6105-28215 |
| Osteosarcoma-Tumor-Assessment |
P9-B7-7568-14821 |
P9-B7-7568-14821 |
| Osteosarcoma-Tumor-Assessment |
P9-B7-8325-33733 |
P9-B7-8325-33733 |
| Ovarian Bevacizumab Response |
1038407 |
1832850C |
| Ovarian Bevacizumab Response |
1038407 |
1832850D |
| Ovarian Bevacizumab Response |
1038407 |
P001832850D |
| Ovarian Bevacizumab Response |
1150997 |
1739259-E-Y |
| Ovarian Bevacizumab Response |
1150997 |
1739259-G-Y |
| Ovarian Bevacizumab Response |
1374299 |
1941494-C-Y |
| Ovarian Bevacizumab Response |
1374299 |
1941494-D-Y |
| Ovarian Bevacizumab Response |
1374299 |
1941494-F-Y |
| Ovarian Bevacizumab Response |
1374299 |
1941494-G-Y |
| Ovarian Bevacizumab Response |
1374299 |
1941494-H-Y |
| Ovarian Bevacizumab Response |
1503203 |
1512129I-N |
| Ovarian Bevacizumab Response |
1647314 |
1813872A |
| Ovarian Bevacizumab Response |
1647314 |
1813872B |
| Ovarian Bevacizumab Response |
1647314 |
1813872C |
| Ovarian Bevacizumab Response |
1647314 |
1813872D |
| Ovarian Bevacizumab Response |
1647314 |
1813872E |
| Ovarian Bevacizumab Response |
1647314 |
3maintenance10-P001813872B |
| Ovarian Bevacizumab Response |
1717872 |
1713372B |
| Ovarian Bevacizumab Response |
1717872 |
1713372E |
| Ovarian Bevacizumab Response |
1717872 |
1713372F |